刘颖
Ying Liu

Ph.D., Professor 
Beijing University, China  

教授 
未来技术学院副院长 
分子医学研究所副所长 
HHMI国际研究学者 
科学探索奖获得者 
国家杰出青年基金获得者 

刘颖教授从事细胞应激和稳态调控的研究，主要关注于细胞对线粒体胁迫和氨基酸匮乏的感知和响应机制。这些过程的失衡与癌症和代谢疾病密切相关，也是衰老的重要诱因。现为北大-清华生命科学联合中心、北京市未来基因诊断高精尖创新中心研究员，美国霍华德休斯医学研究所(HHMI)国际研究学者。入选国家杰青、“万人计划”科技创新领军人才，获科学探索奖、中国青年女科学家奖等。 

Ying Liu is a Principal Investigator of the Beijing Advanced Innovation Center for Genomics, PKU-THU Center for Life Sciences, and Institute of Molecular Medicine at Peking University. She received her B.S. degree in Biochemistry from Nanjing University in 2006, and her Ph.D. degree in Biochemistry in 2011 from the University of Texas Southwestern Medical Center. As a Helen Hay Whitney Fellow, she obtained her postdoctoral training with Prof. Gary Ruvkun at Harvard. On December 2013, she started her own independent lab at Peking University. Dr. Liu’s honors and awards include the HHMI International Research Scholar, China Young Female Scientist Award, Innovators under 35 China from MIT Technology Review, the Nominata Award, and the Stanford Biochemistry Founders' Award for Doctoral Excellence. 

Dr.Liu has a long-lasting interest in stress response and homeostatic regulation. In particular, they focus on the molecular mechanisms that govern cellular and organismal responses to mitochondrial stress (low-energy level) and amino acids deprivation (lownutrient level). In addition, they are currently active exploring the physiological function and regulation of N6-methyldeoxyadenine (DNA 6mA) in stress responses. Failure to appropriately respond to different stresses and maintain homeostasis could result in multiple diseases. Therefore, their studies will have therapeutic potential for the treatment of cancer, metabolic disorders, neurodegeneration or aging.